Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $149.59 billion. The enterprise value is $160.41 billion.
Important Dates
The last earnings date was Wednesday, April 23, 2025, before market open.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.48 billion shares outstanding. The number of shares has increased by 1.11% in one year.
| Current Share Class | 1.48B |
| Shares Outstanding | 1.48B |
| Shares Change (YoY) | +1.11% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 90.89% |
| Float | 1.47B |
Valuation Ratios
The trailing PE ratio is 73.80 and the forward PE ratio is 34.31. BSX's PEG ratio is 2.96.
| PE Ratio | 73.80 |
| Forward PE | 34.31 |
| PS Ratio | 8.49 |
| Forward PS | 7.57 |
| PB Ratio | 6.85 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.96 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 78.94 |
| EV / Sales | 9.14 |
| EV / EBITDA | 34.82 |
| EV / EBIT | 48.26 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.44 |
| Debt / FCF | n/a |
| Interest Coverage | 10.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.45% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BSX has paid $454.00 million in taxes.
| Income Tax | 454.00M |
| Effective Tax Rate | 18.32% |
Stock Price Statistics
The stock price has increased by +46.60% in the last 52 weeks. The beta is 0.73, so BSX's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +46.60% |
| 50-Day Moving Average | 99.49 |
| 200-Day Moving Average | 89.81 |
| Relative Strength Index (RSI) | 58.47 |
| Average Volume (20 Days) | 10,647,843 |
Short Selling Information
The latest short interest is 13.10 million, so 0.89% of the outstanding shares have been sold short.
| Short Interest | 13.10M |
| Short Previous Month | 12.87M |
| Short % of Shares Out | 0.89% |
| Short % of Float | 0.89% |
| Short Ratio (days to cover) | 1.60 |
Income Statement
In the last 12 months, BSX had revenue of $17.55 billion and earned $2.03 billion in profits. Earnings per share was $1.37.
| Revenue | 17.55B |
| Gross Profit | 12.09B |
| Operating Income | 3.32B |
| Pretax Income | n/a |
| Net Income | 2.03B |
| EBITDA | 4.61B |
| EBIT | 3.32B |
| Earnings Per Share (EPS) | $1.37 |
Full Income StatementBalance Sheet
The company has $414.00 million in cash and $11.23 billion in debt, giving a net cash position of -$10.81 billion or -$7.31 per share.
| Cash & Cash Equivalents | 414.00M |
| Total Debt | 11.23B |
| Net Cash | -10.81B |
| Net Cash Per Share | -$7.31 |
| Equity (Book Value) | 22.00B |
| Book Value Per Share | 14.76 |
| Working Capital | n/a |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 68.90%, with operating and profit margins of 18.94% and 11.58%.
| Gross Margin | 68.90% |
| Operating Margin | 18.94% |
| Pretax Margin | 14.12% |
| Profit Margin | 11.58% |
| EBITDA Margin | 26.24% |
| EBIT Margin | 18.94% |
| FCF Margin | n/a |